- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 39/11 - Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
Patent holdings for IPC class C07C 39/11
Total number of patents in this class: 61
10-year publication summary
5
|
6
|
1
|
1
|
5
|
4
|
7
|
6
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Unigen, Inc. | 108 |
6 |
Commissariat à l'énergie atomique et aux energies alternatives | 10922 |
3 |
Novartis AG | 10886 |
2 |
Robert Bosch GmbH | 42614 |
2 |
Sumitomo Chemical Company, Limited | 9031 |
2 |
DSM IP Assets B.V. | 5603 |
2 |
Lonza Ltd. | 610 |
2 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 824 |
2 |
University College Dublin, National University of Ireland, Dublin | 356 |
2 |
Cava Healthcare Inc. | 13 |
2 |
Pharmaceutique Ingenew Inc. | 3 |
2 |
American BioProcess Limitada | 6 |
2 |
L'OREAL, Société Anonyme | 15393 |
1 |
The Regents of the University of California | 19857 |
1 |
International Business Machines Corporation | 61185 |
1 |
Chevron Oronite Company LLC | 572 |
1 |
President and Fellows of Harvard College | 5964 |
1 |
Albemarle Corporation | 492 |
1 |
Aquanova AG | 52 |
1 |
Aquinox Pharmaceuticals (Canada) Inc. | 10 |
1 |
Other owners | 24 |